Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
1
13%
Ph phase_1
1
13%
Ph not_applicable
3
38%
Ph phase_3
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

terminated113%
unknown225%
completed450%
not_yet_recruiting113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_1

MIBG With Dinutuximab +/- Vorinostat

NCT03332667
unknown

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

NCT03649438
not_yet_recruitingnot_applicable

Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples

NCT05628506
unknownnot_applicable

Seaweed, the Food Matrix, and Iodine Bioavailability

NCT04867291
completed

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

NCT04686006
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03332667Phase 1

MIBG With Dinutuximab +/- Vorinostat

Completed
NCT03649438

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

Unknown
NCT05628506Not Applicable

Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples

Not Yet Recruiting
NCT04867291Not Applicable

Seaweed, the Food Matrix, and Iodine Bioavailability

Unknown
NCT04686006

Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects

Completed
NCT02771704Not Applicable

Diamine Silver Fluoride and Potassium Iodide

Completed
NCT00946296Phase 4

Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease

Completed
NCT00379535Phase 3

Preventing Lack of Iodine During Pregnancy

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8